Adjuvant Chemotherapy for Early Breast Cancer
Author Information
Author(s): I.C. Henderson
Primary Institution: Dana-Farber Cancer Institute
Hypothesis
Can adjuvant chemotherapy improve survival rates in women with early breast cancer?
Conclusion
Adjuvant chemotherapy can significantly improve survival rates in premenopausal women with early breast cancer, but its benefits in older women are less clear.
Supporting Evidence
- Adjuvant chemotherapy can prolong the time to recurrence in younger women.
- Three studies show significant survival improvements for premenopausal women receiving chemotherapy.
- Older women do not experience the same survival benefits from chemotherapy as younger women.
Takeaway
Chemotherapy after surgery can help younger women with breast cancer live longer, but it doesn't seem to help older women as much.
Methodology
Overview of multiple adjuvant chemotherapy trials and their outcomes.
Potential Biases
The results may be influenced by the varying quality and size of the trials included in the overview.
Limitations
The benefits of chemotherapy are not consistent across all age groups, and the overall survival improvements are often small.
Participant Demographics
Focus on premenopausal and postmenopausal women with early breast cancer.
Statistical Information
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website